EDN ELISA Kit
The EDN ELISA Kit measures Human EDN by sandwich ELISA.
Microwells, EDN standard, Assay diluent, Conjugate, Wash concentrate, Substrate, Stop solution, Positive control, Negative control
The EDN ELISA Kit measures Human EDN by sandwich ELISA. This ELISA detects Human EDN with a minimum detection limit of 0.62 ng/mL and does not cross-react with ECP.
Samples to be measured or standards are incubated in the wells coated with anti-human EDN monoclonal antibody. After washing, the peroxidase conjugated anti-human EDN polyclonal antibody is added into the microwells and incubated. After another washing, the peroxidase substrate is mixed with the chromogen and allowed to incubate for an additional period of time. An acid solution is added to each microwell to terminate the enzyme reaction and to stabilize the color development. The optical density (O.D.) of each microwell is measured at 450 nm using a microplate reader. The concentration of Human EDN is calibrated from a dose response curve based on the reference standards.
|Product Type:||ELISA Kit|
|Research Area / Disease:||Immunology|
|Gene ID Human:||6036|
|Gene ID Mouse:||24088|
|Regulatory Statement:||For Research Use Only. Not for use in diagnostic procedures.|
- Månssom, A., et al., J. Leu. Biol. 85, 719-727 (2009)
- Gaudreault, É., et al., J. Immunol. 180, 6211-6221 (2008)
- Mathur, S. K., et al., CHEST 133, 412-419 (2008)
- Munitz, A., et al., J. Immunol. 177, 77-83 (2006)
- Morokata, T., et al., J. Pharmacology and Experimental Therapeutics 317, 244-250 (2006)
- Decot, V., et al., J. Immunol. 174, 628-635 (2005)
- Thomas, L. L., et al., J. Immunol. 169, 993-999 (2002)
- Nagase, H., et al., J. Immunol. 164, 5935-5943 (2000)
- Slifman, N. R., et al., J. Immunol. 143, 2317-2322 (1989)
- Gullberg, U., et al., Biochem. Biophis. Res. Commun. 139, 1239-1242 (1986)
- Slifman, N. R., et al., J. Immunol. 137, 2913-2917 (1986)
- Peterson, C. G. B., et al., Immunology 50, 19-26 (1983)
- Durack, D.T., et al., PNAS. 78, 5165-5169 (1981)
- Choi Y et al. Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma. Exp Mol Med. 50, 104 (2018)
- Tsuda T et al. Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity. Int Immunol. (2018) In press.
- Kim JK et al. GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections. Nat Commun. 9, 4184 (2018)
- Ito R et al. A humanized mouse model to study asthmatic airway inflammation via the human IL-33/IL-13 axis. JCI Insight. (2018) In press.rn